Speech Learning and Speech Production in Parkinson's Disease

This study is looking at how people with Parkinson's disease (a brain disorder that affects movement) learn and produce speech. Researchers want to understand the connection between difficulties with talking and difficulties with understanding speech. You would participate in behavioral tasks involving sound intensity and spoken rate. This includes pairing sentences to colored squares and identifying if sentences have the same or different sound intensity or spoken rate. The study aims to see if these learning challenges can predict differences in how people speak. To join, you need to have Parkinson's disease, be a native North American English speaker, use a drug that includes levodopa, and live in the United States. The study is looking for 50 participants, but its current status is unclear.

Study design
This is an interventional study with a planned enrollment of 50 participants. It is not specified if it is randomized or blinded.
What's involved
You would participate in behavioral tasks involving sound intensity and spoken rate, such as pairing sentences to colored squares and indicating if sentences are the same or different.
Compensation
Not stated in the trial record.
Follow-up
Primary endpoints for speech measurements are taken at Day 1.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07403539

Speech Learning and Speech Production in Parkinson's Disease

Recruiting
NAAges 45+InterventionalBasic science
State University of New York at Buffalo
~50 participants
Updated 2026-02-11 on ClinicalTrials.gov
What's tested:Intensity learningIntensity discriminationRate learningRate discrimination

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Mean dB SPL
Measured over Day 1
+4 more outcomes measured
Parkinson's Disease

NCT07403539

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • State University of New York at Buffalo

    Buffalo, New Yorkstudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Diagnosis of Parkinson's disease
Native speaker of North American English
Use a drug that includes levodopa
Resident of the United States

Exclusion

Any history of language, hearing or speech disorder outside of Parkinson's disease
Other gross neurological impairment such as Alzheimer's disease or stroke
Significant hearing loss and/or use of a hearing aid or cochlear implant
  • Mean dB SPLDay 1

    The mean speech intensity (in dB SPL) will be assessed using a recording of spoken sentences and a spoken paragraph.

  • Standard deviation dB SPLDay 1

    The standard deviation of participant's speech intensity (in dB SPL) will be assessed using a recording of spoken sentences and a spoken paragraph.

  • Speaking rateDay 1

    The speaking rate (in syllables/second) will be assessed using a recording of spoken sentences and a spoken paragraph.

  • Articulation rateDay 1

    The articulation rate (in syllables/second after removing pauses) will be assessed using a recording of spoken sentences and a spoken paragraph.

  • Unfilled pause timeDay 1

    The unfilled pause time (in seconds of pause) will be assessed using a recording of spoken sentences and a spoken paragraph.